NEW YORK, Oct. 24 – A limping economy set back Applied Biosystems’ profit by 34 percent in the first quarter while reduced research spending shrank Celera Genomics’ losses in the period, the companies said separately on Wednesday.

However, Celera said it was expecting sales growth of between 40 percent and 50 percent in the new fiscal year, which for it began on Oct. 1, as it signs on new customers for its gene database. Applied Biosystems, meanwhile, has targeted a growth of between 7 percent and 9 percent, Celera said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.